M

MGI Tech Co Ltd
SSE:688114

Watchlist Manager
MGI Tech Co Ltd
SSE:688114
Watchlist
Price: 48.81 CNY -2.03% Market Closed
Market Cap: 20.3B CNY
Have any thoughts about
MGI Tech Co Ltd?
Write Note

MGI Tech Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MGI Tech Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
M
MGI Tech Co Ltd
SSE:688114
Cash & Cash Equivalents
ÂĄ4.8B
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash & Cash Equivalents
ÂĄ14.7B
CAGR 3-Years
14%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash & Cash Equivalents
ÂĄ2.3B
CAGR 3-Years
-27%
CAGR 5-Years
46%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash & Cash Equivalents
ÂĄ9.2B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash & Cash Equivalents
ÂĄ3.2B
CAGR 3-Years
-28%
CAGR 5-Years
9%
CAGR 10-Years
33%
W
WuXi XDC Cayman Inc
HKEX:2268
Cash & Cash Equivalents
ÂĄ4B
CAGR 3-Years
422%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MGI Tech Co Ltd
Glance View

Market Cap
20.1B CNY
Industry
Life Sciences Tools & Services

MGI Tech Co., Ltd. engages in the research and development, production, and sale of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. The company is headquartered in Shenzhen, Guangdong and currently employs 2,805 full-time employees. The company went IPO on 2022-09-09. The firm is mainly engaged in three businesses. The gene sequencer business mainly includes the development of small and medium-sized desktop sequencers and large and ultra-large sequencers, and the establishment of a full range of multi-model product matrix to meet the needs of users in different application scenarios. The laboratory automation business mainly includes the development of automated sample processing systems, laboratory automation pipelines, sample processing reagent consumables and other laboratory automation products. The new business mainly includes cytomic solutions, remote ultrasound robots and bioinformation Technology (BIT) products.

Intrinsic Value
44.8 CNY
Overvaluation 8%
Intrinsic Value
Price
M

See Also

What is MGI Tech Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
4.8B CNY

Based on the financial report for Dec 31, 2023, MGI Tech Co Ltd's Cash & Cash Equivalents amounts to 4.8B CNY.

What is MGI Tech Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
20%

Over the last year, the Cash & Cash Equivalents growth was -26%. The average annual Cash & Cash Equivalents growth rates for MGI Tech Co Ltd have been 20% over the past three years .

Back to Top